mRNA |
ZG-10 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.01 |
mRNA |
GW 441756 |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.02 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |